BIOA · BioAge Labs, Inc. · Proposed Sales
Market Cap
$389.66M
Shares
45.90M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-06-30 | Barton Shane | Officer | 20,216 | 2026-06-30 | Fidelity Brokerage Services LLC |
| 2026-06-29 | Barton Shane | Officer | 42,350 | 2026-06-29 | Fidelity Brokerage Services LLC |
| 2026-04-01 | RUBIN PAUL D | Officer | 8,820 | 2026-04-01 | Fidelity Brokerage Services LLC |
| 2026-03-02 | RUBIN PAUL D | Officer | 7,433 | 2026-03-02 | Fidelity Brokerage Services LLC |
| 2026-02-02 | RUBIN PAUL D | Officer | 7,433 | 2026-02-02 | Fidelity Brokerage Services LLC |
| 2026-01-13 | GOLDSTEIN DOV A MD | Officer | 27,000 | 2026-01-13 | Fidelity Brokerage Services LLC |
| 2026-01-13 | Fortney Kristen | 10% Stockholder | 233,107 | 2026-01-13 | RAYMOND JAMES & ASSOCIATES |
| 2026-01-02 | RUBIN PAUL D | Officer | 7,433 | 2026-01-02 | Fidelity Brokerage Services LLC |
| 2025-12-09 | RUBIN PAUL D | Officer | 18,000 | 2025-12-09 | Fidelity Brokerage Services LLC |
| 2025-12-04 | RUBIN PAUL D | Officer | 68,897 | 2025-12-04 | Fidelity Brokerage Services LLC |
Showing 1–10 of 10 filings
Key facts
CIK
1709941
CUSIP
09077V100
13F (30d)
67 filings
67 filers
Visit website
Investor relations